Subject: RE: link to resources
From: "KAUCLEY, Landry" <[email-masked]>
To: Shipra Srihari <[email-masked]>, "[email-masked]" <[email-masked]>
Cc: Grace Chee <[email-masked]>, Tesfaye Dereje <[email-masked]>, Neha Acharya <[email-masked]>
Date: Mon, 14 Jan 2019 13:54:58 +0000

Good day Shipra!

Thank you for your message. The mail from Tesfaye was well received.

We keep in touch.

Best

------------------------------------------------

Landry
Kaucley, MD, MSc | Economiste et Gestionnaire de Santé Publique, Vaccinologue | Directeur de la Logistique ANV/SSP  BENIN |Cel 1: +229-97-051-300 | Cel
2: +229-95-449-006| E-mail:
[email-masked]
ou [email-masked]

'Le
succès n'est pas au bout du chemin. Il est dans ta démarche même' --- François Garagnon

De : Shipra Srihari

Envoyé : lundi 7 janvier 2019 19:54

À : [email-masked]; [email-masked]

Cc : Grace Chee; Tesfaye Dereje; Neha Acharya

Objet : link to resources

Dear Keti and Landry,

I hope you received the follow-up email from Tesfaye that shared links for the various materials we’ve produced. Thanks again for your valuable participation and input!!

I just wanted to point you to the link for the podcast, which includes clips of both of you speaking in the webinar. Unfortunately, the quality of the recording of the webinar was not clear enough for the podcast, so we had to have our
Communications staff speak your points. We prepared a transcript for them, which they then read out, to make sure that what they said was the same as what you did! You’ll hear your names and you’ll hear your voices as you start speaking, and then you’ll notice
that someone else’s voice then continues with your speaking points.

http://podcasts.abtcapabilities.com/producing-and-using-immunization-expenditure-data.html

Thanks again, and please do reach out if you have any questions.

Kind regards,

Shipra

Shipra Srihari, PhD MPH | Associate

International Development Division | Abt Associates

O: 617.520.3919 | www.abtassociates.com

This message may contain privileged and confidential information intended solely for the addressee. Please do not read, disseminate or copy it unless you are the intended recipient. If this message has been received in error, we kindly ask that you notify the
sender immediately by return email and delete all copies of the message from your system.